| TOP STORY | Next Steps in Potential Stem Cell Therapy for Diabetes There are currently two ways of generating endocrine cells from human embryonic stem cells (hESCs), either generating the cells in vitro in culture or transplanting immature endocrine cell precursors into mice. Researchers looked at the differences and similarities between these two types of hESC-derived endocrine cell populations and primary human endocrine cells, with the longer-term goal of developing new stem cell therapies for diabetes. [Press release from the University of California, San Diego Health Sciences discussing online prepublication in Cell Stem Cell] Press Release | Abstract | Graphical Abstract |
|
|
|